chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt was in for her physical on 8/5/2020 w/ no noted abnormality of her neck/thyroid.  She was then in on 2/15 after receiving her 1st and 2nd dose (2/3/21) of Moderna.  She presented w/ concerns of a lump on her neck.  Upon exam she stated to the provider that she and noticed tingling in her neck after the first injection. She then had labs done that day w/ our clinic, this was followed by a biopsy of the lump.  She was then referred over to a healthcare facility for treatment/surgical intervention.  To our knowledge she had a thyroidectomy done and is now following with the healthcare facility.
Within 4 days of 1st Pfizer vaccine for COVID, developed fatiguable diplopia confirmed associated with vertical eye misalignment.
This spontaneous report as received from a registered medical assistant refers to unknown number of patients of unknown age and gender. On an unknown date, the unknown number of patients were vaccinated with GARDASIL. On an unknown date the patient may had received improperly storaged GARDASIL. No adverse effects reported. This is one of several reports from the same source. Additional information is not expected.
Covid19 breakthrough.  1st Vaccine received on 03/01/2021.  74 y/o with PMHx Breast Cancer(DCIS), Dermatomyositis, asthma, T12 fracture and osteopenia presents to ED with 2 week complaint of SOB, chills, productive cough with brown sputum.  Intially at home pt was prescribed 5 day course of antibiotics and steroids but symptoms worsened.  Pt tested for + Covid 5 days ago after no response to home treatment.  Pt arrived to ED with room air sat 82%, placed on 5L NC.  CXR-new multilobar PNA, afebrile.  Started on IV ABX, Steroids, Baricitinib and Remdesivir.
Mayocarditis; started as a feeling like I had a very bad viral infection on 5/18. Then 5/20 I started getting intense chest pain and went to Hospital where I was admitted for 5 days. They observed my condition and gave me Ibuprofen, Motrin, and Colchicine. Released on 5/25 once my fever broke.
temperature excursion (>0° to <2°C for =72 hours), with no reported adverse event; Initial information received on 11-Jan-2022 regarding an unsolicited valid non-serious case was received from the health professional.  This case involves an unknown age and unknown gender patient, who had temperature excursion (>0° to <2°c for =72 hours), with no reported adverse event while receiving vaccine TETRAVALENT (CHIMERIC) DENGUE VACCINE [DENGVAXIA].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect TETRAVALENT (CHIMERIC) DENGUE VACCINE (strength, formulation, dosage regimen, lot number not reported) via unknown route in unknown administration site for prophylactic vaccination. Information on batch number was requested.  On an unknown date, the patient developed a non-serious event 'temperature excursion (>0° to <2°c for =72 hours), with no reported adverse event' (product temperature excursion issue) (unknown latency) following the administration of TETRAVALENT (CHIMERIC) DENGUE VACCINE.  It is reported "This is reported as potential AE because of temperature excursion."  Action taken with DENGUE VACCINE (DENGVAXIA) was not applicable.  At time of reporting, the outcome was Unknown for the event temperature excursion (>0° to <2°c for =72 hours), with no reported adverse event.
I am unsure if this illness was related to his recent vaccination. However, after seeing reading this article about possible link between covid vaccination and the development of myocarditis, I felt compelled to report:  https://www.reuters.com/world/middle-east/israel-examining-heart-inflammation-cases-people-who-received-pfizer-covid-shot-2021-04-25/.  The patient in question is a 53 year old man with a history of previous carotid artery dissection and hyperlipidemia transferred to our hospital from an outside facility for presumed myocarditis. He rapidly decompensated, required intubation, multiple vasopressors, was initiated and ultimately expired.
Initial and follow-up information has been received from a nurse, for the Pregnancy Registry for GARDASIL, concerning a 23 year old female smoker with a history of one pregnancy which the infant had gastroschisis and was pre-term premature rupture of fetal membranes at 32 weeks and pre-term delivery. On 19-MAY-2008 the patient was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL (lot no. 659182/1757U) into the right deltoid. There was no concomitant medication. The patient is now pregnant. On 18-JUN-2008 the patient had ultrasound done for dating and the result was normal embryo. On an unspecified date the patient had routine blood and laboratory tests done and no results reported. No problems reported. The patient sought unspecified medical attention. Follow-up information has been received from a complete pregnancy questionnaire. The patient was taking prenatal vitamin, 1 tablet daily in the entire pregnancy. On approximately 15-SEP-2008 the patient developed bacterial vaginosis. On 15-SEP-2008, the patient was prescribed metronidazole, 500 mg, twice a day for 7 days for the treatment of bacterial vaginosis on 15-SEP-2008, the patient developed chlamydia. On 16-SEP-2008, the patient was prescribed ZITHROMAX, 1 gram once for the treatment of chlamydia. On an unspecified date, the patient developed Group B streptococcal infection. The outcome of the events was unknown. On 07-FEB-2009, the patient delivered a normal baby girl with no congenital anomalies for complications at the 40 weeks gestation. The baby weighted 7 pounds and 4 ounces. The length was 21 inches (53.3 cm). The Apgar score was 8/9 and the head circumference was 33.5 cm. It was reported that there was no complication during pregnancy and delivery. Additional information is not expected.
Feeling burning sensation going through my body, Its been coming and going its been on different spot ,feels like its just moving around; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiry date was not reported, age at vaccination: 36-year-old), via an unspecified route of administration on 22May2021 at 05:00 as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included spironolactone (SPIRONOLACTONE) taken for an unspecified indication, start and stop date were not reported. The patient got the vaccine around 5 o'clock on 22May2021 and not more than like minute she started showing like a feeling burning sensation going through her body, it's been coming and going it's been on different spot, feels like it's just moving around and she just thinking now if that was something other people have experienced or is it something she should be concerned about. The patient doesn't know what to take as corrective treatment. The outcome of event was unknown.   Information about the lot/batch number has been requested.
One month, post vax, I had numbness in half my face. After several doctor visits, 3 MRI's, Spinal Tap and going to the hospital, I was dx'd with Multiple Sclerosis. I also developed optic neurosis and still have numbness in my body.
Seven days following the first dose, I noticed that my left arm was itchy around and underneath the injection site.  The following day a rash developed underneath the injection site and spread up to the top of my bicep.  On day 8 post injection, the muscle looked a little swollen and the rash itched a little bit.  On day 9, the rash was not as red and the site did not look as swollen.  The redness has gone down on day 9 and it is still mildly itchy.
EMPLOYEE OBSERVATION TIME WAS UP AND EMPLOYEE STOOD UP AND STATED SHE DID NOT FEEL WELL AND SHE FELT LIKE SHE WAS ABOUT TO BE SICK AND ASKED INFECTION CONTROL STAFF WHERE THE NEAREST BATHROOM WAS EMPLOYEE STARTED TO RUN TO RESTROOM AND INFECTION CONTROL STAFF HEARD NOISES THAT SOUNDED LIKE EMPLOYEE WAS THROWING UP. WHILE NURSING STAFF WERE WAITING OUTSIDE OF RESTROOM, OUR MEDICAL DIRECTOR DR CAME TO ASSESS EMPLOYEE V/S WERE TAKEN AND WNL. DR UPON HIS ASSESSMENT DETERMINED THAT EMS NEEDED TO BE SUMMONED WHILE WAITING FOR EMS EMPLOYEE COMPLAINED SHE HAD TO DIARRHEA AND STARTED TO HAVE UNCONTROLLED DIARRHEA, AFTER EMPLOYEE WAS DONE WITH USING RESTROOM SHE BEGAN TO GAG AND THROW UP CLEAR FLUID SHORTLY AFTER EMS ARRIVED AND TOOK OVER EMPLOYEE.
patient had the 1st dose of the Pfizer Covi-19 vaccine and was accidentally given the Moderna Covid-19 vaccine as a 2nd dose.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (patient had the 1st dose of the Pfizer Covi-19 vaccine and was accidentally given the Moderna Covid-19 vaccine as a 2nd dose.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (patient had the 1st dose of the Pfizer Covi-19 vaccine and was accidentally given the Moderna Covid-19 vaccine as a 2nd dose.). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (patient had the 1st dose of the Pfizer Covi-19 vaccine and was accidentally given the Moderna Covid-19 vaccine as a 2nd dose.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported.  No treatment medication reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow up received contains No new Information On 24-Jul-2021: No new information
Few hours after receiving vaccine patient started experiencing shoulder/arm pain. Got so bad he went to ER, came to office 8/14, had developed linear array of microvessicles & redness 2.5" long.
Patient was sitting in the pharmacy waiting area after receiving her COVID vaccination.  One of my technicians noticed the patient looked barely conscious.  We called Fire Department and EMS arrived within 10-15 minutes.  While we were waiting I and 2 others stayed with the patient.  We took her vitals. BP and pulse were 116/76, heart rate 76.  Patient was clammy and sweaty and was semi-conscious.  We were able to communicate with her.  EMS arrived and ran more tests.  Patient's vitals were fine except she had orthostatic hypotension.  She also reported a history of syncope (this was not noted in her questionnaire).  Patient did not want to go with EMS.  Her fiance's mother came and picked her up.
Myalgia night sweats, chills, fatigue Narrative: Employee received vaccine on 12/30/2020 and began experiencing symptoms (chills, fatigue, night sweats, body aches) on 12/31/2020. Reports took "pain pills" however no information to dose/frequency or name of medication provided. Employee reports has not fully recovered as of 01/06/2021.
I continue to have severe breathing issues; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (I continue to have severe breathing issues) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced DYSPNOEA (I continue to have severe breathing issues). At the time of the report, DYSPNOEA (I continue to have severe breathing issues) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information were not provided.   Reporter did not allow further contact
3:14pm-Tdap, MMR given per pt. request. Observed for 15 min. Pt's s/s of reaction. 3:40 Pt scratching scalp. Assessed upper thorax red blotchy areas appearing around neck also right upper c area no airway problems. BENADRYL 25mg given po, swallowed OK. 3:54 Pt left under own power, laughing and talking with daughter accompanied by mother.
Initial report was received 19 April 2011 from a health care professional via another manufacturer (Service Request Number 1-4102833495). A female patient whose age, date of birth and medical history were not reported, had received swine influenza vaccine in 1979 (manufacturer, lot number, route, site and exact date of vaccination not reported), and an unspecified amount of time later in 1979, the patient developed Guillain Barre syndrome. The patient received corrective treatment (not specified) and lab diagnostic studies were reported as N/A. The report further indicated that the patient did not die; however; the remainder of seriousness criteria and the patient's outcome were reported as "N/A". No additional information was provided. The reporter requested not to be contacted for follow-up. Documents held by sender: None.
15JAN while changing child diaper notice a large lymph node in rt groin area;about the size of a large marble or small walnut;called the hlth dept where vax recv;
5-1-21 Woke up with hives covering 35% of body; took Benedryl throughout day; 5-2-21 Woke up with hives covering 85% of body; Received steroid injection, started steroid dose pack, 2 additional antihistamines.  Took 4-5 days for hives to completely go away.  Then on 5-10-21 and 5-11-21 Body aches, headache, and 102.3 fever.  Unable to get much relief with ibuprofin and acetominaphen.
Following the second Covid vaccination, the next day awoke with a headache (lasted only 1 day) and with tinnitus which has continued persistently with no respite. Visited my primary care physician who referred me to an ENT. She performed tests to confirm the tinnitus and no hearing loss, was informed that there is no cure but that the best solution available was masking the issue.
3:00 PM - patient reports being very tired, "feel like arm is falling off" and nauseous 5:00 PM - chills and teeth chattering 7:00 PM - emesis 10:30 PM - fever 102 degrees F, chills, unable to sleep Missed work on 10/22/2010 due to fatigue
Cold and flu symptoms 1.5 weeks so far. Hit and cold flashes. Coughing blood and congestion. Overall weakness. Injection site still sore.
During administration of vaccines client experienced brief episode of syncope. Client returned to consciousness within a few seconds. Parent present. Client placed in supine position with legs elevated. Within 10 minutes client stated no dizziness or other symptoms. Client able to sit up and then stand up without difficulty or symptoms. Vital signs stable. No additional medical interventions necessary. Client ambulatory and accompanied by parent at discharge from clinic.
This spontaneous report as received from a health professional refers to a 14 year old patient of unknown gender. On 25-JAN-2016, the patient was vaccinated with a second dose of GARDASIL lot # K008931 (expiration date 04-MAR-2016) in the right arm (dose and route were not reported), which was stored for 15 hours and 15 minutes in a 33 Fahrenheit (F) degrees. There was no previous temperature excursion and the call was not because of a data logger. Additional information is not expected, as all required correspondence was received.
The patient became very emotional with more anxiety than she had ever experienced before. She had intermittent episodes of chest pain with shortness of breath. This lasted several weeks. It was over by the time she reported this to me 08/02/2022.
Information has been received from a Licensed Practical Nurse concerning 12 month old patient of unknown gender. The patient's pertinent medical history, drug reactions, allergies or concurrent conditions were not reported. On 03-OCT-2016, the patient was vaccinated with an improperly stored dose of PEDVAXHIB for prophylaxis (lot number L051123 with an expiration date of 13-OCT-2018) (dose, frequency, route of administration and anatomical location were not reported). Other suspect and concomitant medications were not provided. There was no adverse effect reported. The doses of the vaccine experienced a temperature excursion of 1 degree Celsius (C) for a time frame of 48 hours. A digital data logger was involved. There were no previous temperature excursions. Furthermore, no product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1610USA013756.
Patient received the second dose in the series 2 days early.  No adverse effects occurred due to early administration.
swelling of joints of knees & especially wrists;legs turned black;finished series;bitten by known rabid cat;seen by allergist & dx w/hemorrhagic chicken pox;then started to loose weight for a total of 23lbs to date;normally a thing person
Swelling and pain at left upper arm/deltoid with mild cellulitis 2 hours to immunizations received 07/09/2003.
Mom states no problems this am before dropping off at daycare. Daycare called her because she was running a fever, right arm was swollen. Child was brought back into health department today. Redness noted in right upper arm, almost completely around and slightly to upper chest. No decreased movement noted. Warm to touch; crying with high pitch cry.
Information has been received from a registered nurse concerning an 84 year old female with asthma and a history of hypertension hypothyroidism, bladder neoplasm and lymphoma, who on 17-SEP-2009 was vaccinated with her third dose of PNEUMOVAX 23 (lot # 663486/0507Y). She received 2 previous PNEUMOVAX 23 vaccines many years ago with no problem. On 17-SEP-2009 after the third vaccination, the patient developed what was described as "more of a reaction than you would expect". She had severe pain and swelling in her injection arm. It was reported as a 7 out 10 on a pain scale. She could barely move her arm. She self treated with TYLENOL and ice and it resolved within 48 hours. The patient went to office for medical attention. The reporter would like a lot check. Follow up has been received from a registered nurse through a telephone call indicating that the patient called the physician and complained of severe pain and swelling, and she could barely move her arm. The patient was treated with TYLENOL and warm compresses. The patient recovered. Follow up has been received from a registered nurse concerning an 84 year old female with a history of hypothyroidism, asthma, hypertension and osteoarthritis, lymphoma, aneurysm and no illness at time of vaccination, who on 17-SEP-2009 at 2:58 PM was vaccinated with her third dose of PNEUMOVAX 23 (lot # 663486/0507Y) IM in the left arm. She has received 2 doses of PNEUMOVAX 23 vaccines in past and never had reaction. Concomitant therapy included the first dose of influenza virus vaccine (Sanofi Pasteur, lot # U3199AA) IM in the right arm on 17-SEP-2009 at 2:58 PM. ON 18-SEP-2009 the patient experienced pain and swelling. Her left arm hurt when moved. She was using TYLENOL and ice for treatment. The patient recovered on an unknown date. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. No further information is available.
presented with complaint of pain and swelling in arm at injection site.  also, stated that are at site felt warm.  instructed to use cold compress and to take either Tylenol or ibuprofen for the pain.
VACCINE GIVEN FROM THE VIAL WHICH WAS PUNCTURED AND KEPT IN REFRIGERATOR ONE DAY BEFORE; PUNCTURED VIAL OF VACCINE KEPT IN REFRIGERATOR FOR A DAY; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 23-JUN-2021 for prophylactic vaccination. No concomitant medications were reported.  On 23-JUN-2021, the subject experienced vaccine given from the vial which was punctured and kept in refrigerator one day before. On 23-JUN-2021, the subject experienced punctured vial of vaccine kept in refrigerator for a day. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine given from the vial which was punctured and kept in refrigerator one day before and punctured vial of vaccine kept in refrigerator for a day was not reported. This report was non-serious. This case, from the same reporter is linked to 20210652114.
Started feeling dizzy&nausea  Kept in  Post Vax Area    to monitor     BP 99/66   p93 given snack & water 3p145/94 p100  Bp119/94   p110@1838hrs left after feeling better  . approximately 1840hrs
pt was taken by mom to school clinic to receive 1st dose of pfizer. Dad did not know and brought pt in for first dose of pfizer on 12/18/21. Pt ended up getting both doses of pfizer with only a 13 day window, not the 21 day window.
On April 24, 2018, the date of the vaccination, I initially did not have a reaction. That evening I developed a headache and the area of the injection was painful and eventually I felt rather fatigued. I took 1 ibuprofen. On April 25th, I went to exercise class. After 20 minutes, I became faint--stopped exercise --found I was very fatigued. I left the class. I managed to drive home. For the rest of the day I was in bed, dozing off intermittently and feeling generally very fatigued and unsteady. I felt achy, my arm turned red at the site of the injection and was painful. If there was swelling, it was minimal. I took a generic 500 mg TYLENOL one at a time--three times that day.  April 26th, today, I felt faint upon first getting up in the morning. I felt better after breakfast and took 2 generic TYLENOL. I went to an appointment. At this point, there is only faint pain at the inoculation site. I am able to do some activities and then rest a few minutes. Getting better and have more energy.
L leg 7 x 10 cm red, tender, swollen reaction. -Mom states also had reaction to all DTaP.
Patient reported to be light headed and dizzy before loosing consciousness. Patients vital signs remained stable and patient  came back too after a couple of seconds. Patients V/S 129/53, P:51 RR:18, T:36.2, O2: 100% on RA
Patient came up to pharmacy and complained about rash on all over her arm and chin. She also stated that she got fever one day after the injection. She doesn't feel itchy by rash. She asked for any OTC medication would help the condition better. I recommended BENADRYL 50mg and Hydrocortisone 1% cream. If she doesn't get better within 2 days, contact her PCP right away.